Top Markets
Coin of the day
Incannex Healthcare Limited Incannex Healthcare Limited

Incannex Healthcare Limited

IHL
Classifica tra le azioni #33836
Established in Melbourne, Australia, in 2001, Incannex Healthcare Limited,... Established in Melbourne, Australia, in 2001, Incannex Healthcare Limited, which operated as Impression Healthcare Limited until its rebranding in June 2020, is dedicated to the research, development, and commercialization of pharmaceutical products and therapies derived from medicinal cannabinoids and psychedelics. Its offerings include a trio of ultrapure cannabinoid compounds: APIRx-1801 (tetrahydrocannabinol), APIRx-1802 (CBD), and APIRx-1803 (cannabigerol). The company's clinical pipeline features IHL-42X, which has concluded Phase IIa trials for obstructive sleep apnea, and Psi-GAD, currently in Phase IIa development for generalized anxiety disorder. Other compounds having successfully advanced through Phase IIa clinical trials include CanChew Plus for irritable bowel syndrome, APIRx-1601 for vitiligo, APIRx-1602 for psoriasis, and APIRx-1603 for atopic dermatitis. Additionally, MedChew Dronabinol has completed Phase Ia trials for chemotherapy-induced nausea and vomiting. Its pre-clinical portfolio is extensive, including IHL-675A, which has completed studies for inflammatory lung disease, rheumatoid arthritis, and inflammatory bowel disease, alongside IHL-216A for traumatic brain injury/concussion. A broad array of further candidates are actively undergoing pre-clinical investigation, such as MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpetic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for Crohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for cannabis addiction, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, and APIRx-1702 for dry eye syndrome.
Prezzo delle azioni
$0.0270762
Ultima sincronizzazione: 2023-11-30
Capitalizzazione di mercato
$6.78M
Variazione (1 giorno)
-0.66%
Variazione (1 anno)
0.00%
Paese
AU
Scambia Incannex Healthcare Limited (IHL)

Categoria

Storico del prezzo dell'azione per Incannex Healthcare Limited (IHL)
Prezzo di chiusura più alto: $0.03 il 2023-11-01

Prezzo di chiusura più basso: $4.90 il 2007-05-01
Storico del prezzo dell'azione di Incannex Healthcare Limited dal 2007 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -72.78%
2022 -65.89%
2021 218.18%
2020 169.28%
2019 233.32%
2018 4.26%
2017 -76.05%
2016 -11.66%
2015 37.57%
2014 -70.52%
2013 -83.29%
2012 -9.28%
2011 -46.22%
2010 142.62%
2009 121.48%
2008 -91.13%
2007 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$161.67 23.26%
DE
$35.97 20.03%
JP
$225.00 37.51%
CH
$21.30 13.79%
IN